Article
Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection.
The New England journal of medicine - 9 Aug 2001
Albrecht M A, Bosch R J, Hammer S M, Liou S H, Kessler H, Para M F, Eron J, Valdez H, Dehlinger M, Katzenstein D A
Abstract excerpt
BACKGROUND: The optimal antiretroviral treatment for patients who have human immunodeficiency virus (HIV) viremia despite treatment with nucleoside reverse-transcriptase inhibitors (nucleoside analogues) remains uncertain. We studied treatment with regimens that combined two nucleoside analogues, at least one of which was new, with the protease inhibitor nelfinavir, the nonnucleoside reverse-transcriptase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.